InsiderTrades

Form 4 for RIGL RIGEL PHARMACEUTICALS INC

Accepted 2025-01-28 00:00:00 ET · period of report 2025-01-24 · accession 0000905148-25-000237 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-01-28 2025-01-24 RIGL RODRIGUEZ RAUL R CEO, Pres, Dir F - Tax $22.17 -88.2K 206.5K -30% -$1.95M
DM 2025-01-28 2025-01-24 RIGL RODRIGUEZ RAUL R CEO, Pres, Dir M - OptEx $21.40 +90.0K 249.7K +56% +$1.93M
DM 2025-01-28 2025-01-24 RIGL RODRIGUEZ RAUL R CEO, Pres, Dir M - OptEx $0.00 -90.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-24 F D 44,078 $22.17 205,584 D — —
2 Common Common Stock 2025-01-24 M A 45,000 $21.40 250,584 D — — (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
3 Common Common Stock 2025-01-24 F D 44,078 $22.17 206,506 D — —
4 Common Common Stock 2025-01-24 M A 45,000 $21.40 249,662 D — — (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F2) Includes 1,000 shares acquired under the Issuer's stock purchase plan.
5 Derivative Employee Stock Option (right to buy) 2025-01-24 M D 45,000 $0.00 0 D $21.40 · 2016-04-04 to 2025-01-26 45,000 Common Stock (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
6 Derivative Employee Stock Option (right to buy) 2025-01-24 M D 45,000 $0.00 0 D $21.40 · — to 2025-01-26 45,000 Common Stock (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F3) The shares vested monthly over two (2) years from January 1, 2015.